Ciclopirox Olamine Cream
NDC Package 45802-138-18
Package Information
Ciclopirox Olamine cream is a medication used to treat fungal skin infections such as athlete's foot, jock itch, and ringworm. This formulation utilizes a cream delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-138 and is authorized under FDA application ANDA077364.
Identification & Billing
- RxCUI: 309289 - ciclopirox 0.77 % (ciclopirox olamine 1 % ) Topical Cream
- RxCUI: 309289 - ciclopirox 7.7 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-138 - Ciclopirox Olamine
- 45802-138-18 - 1 TUBE in 1 CARTON / 90 g in 1 TUBE
- 45802-138 - Ciclopirox Olamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (45802-138). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-138-18 identifies a specific commercial package of 1 tube in 1 carton / 90 g in 1 tube of Ciclopirox Olamine, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. This cream is formulated for topical use and contains ciclopirox olamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on July 19, 2006. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat fungal skin infections such as athlete's foot, jock itch, and ringworm. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor), a fungal infection that causes a lightening or darkening of the skin of the neck, chest, arms, or legs. Ciclopirox is an antifungal medication that works by stopping the growth of fungus.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802013818. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.